Claude Nicaise

Dr. Claude Nicaise, MD, is a Chairman at Filana Therapeutics, Inc., an Independent Director at Chemomab Therapeutics Ltd., an Independent Director at Gain Therapeutics, Inc., an Independent Director at Minoryx Therapeutics SL, an Independent Director at Sarepta Therapeutics, Inc., an Owner at Clinical Regulatory Services LLC, a Member at American Society for Microbiology, a Member at American Society of Clinical Oncology, Inc., a Member at American Society of Hematology and a Member at European Society for Medical Oncology.
He is on the Board of Directors at Chemomab Therapeutics Ltd., Gain Therapeutics, Inc., Minoryx Therapeutics SL and Sarepta Therapeutics, Inc. Dr. Nicaise was previously employed as a Head-Research & Development by Ovid Therapeutics, Inc., a Senior Vice President-Global Regulatory Affairs by Alexion Pharmaceuticals, Inc., a Vice President-Global Development by Bristol Myers Squibb Co., a VP-Clinical Development & Regulatory Affairs by Formula Pharmaceuticals, Inc., and a Deputy Medical Officer by Outlook Therapeutics, Inc. He received his doctorate degree from Université Libre de Bruxelles.